T‐cell depleted HLA‐haploidentical HSCT in a child with neuromyelitis optica
release_b5wfdr7ztvhu3aqfj5bpr65j7i
by
Giulia Ceglie, Laura Papetti, Lorenzo Figà Talamanca, Barbarella Lucarelli, Mattia Algeri, Stefania Gaspari, Giuseppina Li Pira, Giovanna‐Stefania Colafati, Mauro Montanari, Massimiliano Valeriani, Franco Locatelli, Pietro Merli
2019 Volume 6, Issue 10, p2110-2113
Abstract
Neuromyelitis optica is an immune-mediated disease characterized by a relapsing course, resulting in progressive disability. In children, given the long life expectancy, a disease-modifying treatment could be particularly desirable. Unfortunately, the currently available treatment strategies with this potential are scarce. Very limited data are available about the use of allogeneic hematopoietic stem cell transplantation (HSCT) for autoimmune neurological diseases. In this report, we present a pediatric case successfully treated with allogeneic HSCT from an HLA-haploidentical donor, after ex vivo TCR/CD19-depletion of the graft. To the best of our knowledge, this is the first case of a pediatric patient to benefit from such a treatment.
In text/plain
format
Archived Files and Locations
application/pdf 373.8 kB
file_d5zklpqfl5arfbqjw2adus4hcm
|
europepmc.org (repository) web.archive.org (webarchive) |
application/pdf 363.6 kB
file_keabjk4cwnefxlbvoveg2qyp6i
|
iris.uniroma1.it (web) web.archive.org (webarchive) |
access all versions, variants, and formats of this works (eg, pre-prints)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar